Literature DB >> 20092984

A standardized aqueous extract of Anoectochilus formosanus modulated airway hyperresponsiveness in an OVA-inhaled murine model.

C-C Hsieh1, H-B Hsiao, W-C Lin.   

Abstract

Anoectochilus formosanus HAYATA, a Chinese herb, is a valued folk medicine for fever, pain, and diseases of the lung and liver. Allergic asthma is characterized by increased serum IgE level and inflammation of the airways with high levels of interleukin (IL)-4 and IL-5 in bronchoalveolar lavage fluids (BALF). Constriction of airway smooth muscle and development of airway hyperresponsiveness (AHR) are the most important symptoms of allergic asthma. In our previous study, a standardized aqueous extract of A. formosanus (SAEAF) was used to modulate innate immunity of normal mice. In this study, airway inflammatory infiltrations, including T cell differentiation, cytokine modulation, allergic antibodies estimation, pulmonary pathology, and enhanced pause (Penh) of AHR were used to evaluate SAEAF treatment of an ovalbumin (OVA)-inhaled airway allergic murine model. The resulting cytokine profiles demonstrated that SAEAF can significantly reduce Th2 polarization after administration of SAEAF in OVA inhalation. These results also suggest that SAEAF modulates cytokine secretion in allergic asthma. Modulated natural T regulatory cells (CD25+/CD4+, Treg) were also shown to increase immuno-suppression in the allergic lung inflammation and further down-regulate airway inflammatory infiltration in eosinophils and macrophages. Finally, decreased airway anti-OVA IgE secretion and reduced AHR were observed. Our results indicate that the administration of SAEAF can modulate cytokines and T cell subpopulation by regulating inflammatory cell infiltration and modulating the allergic response. (c) 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20092984     DOI: 10.1016/j.phymed.2009.12.012

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

Review 1.  Immune Homeostasis: Effects of Chinese Herbal Formulae and Herb-Derived Compounds on Allergic Asthma in Different Experimental Models.

Authors:  Lu Liu; Lin-Peng Wang; Shan He; Yan Ma
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

2.  Molecular cloning of a new immunomodulatory protein from Anoectochilus formosanus which induces B cell IgM secretion through a T-independent mechanism.

Authors:  Yen-Chou Kuan; Tsai-Jen Wu; Che-Yu Kuo; Ju-Chun Hsu; Wen-Ying Chang; Fuu Sheu
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

3.  Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.

Authors:  Hung-Bo Hsiao; Chang-Chi Hsieh; Jin-Bin Wu; Ho Lin; Wen-Chuan Lin
Journal:  BMC Complement Altern Med       Date:  2016-02-25       Impact factor: 3.659

Review 4.  Herbal Medicines for Asthmatic Inflammation: From Basic Researches to Clinical Applications.

Authors:  Fang Liu; Nan-Xia Xuan; Song-Min Ying; Wen Li; Zhi-Hua Chen; Hua-Hao Shen
Journal:  Mediators Inflamm       Date:  2016-07-20       Impact factor: 4.711

5.  Anti-inflammatory and anti-insulin resistance activities of aqueous extract from Anoectochilus burmannicus.

Authors:  Phatcharaporn Budluang; Pornsiri Pitchakarn; Pisamai Ting; Piya Temviriyanukul; Ariyaphong Wongnoppawich; Arisa Imsumran
Journal:  Food Sci Nutr       Date:  2016-08-26       Impact factor: 2.863

Review 6.  Use of Natural Products in Asthma Treatment.

Authors:  Lucas Amaral-Machado; Wógenes N Oliveira; Susiane S Moreira-Oliveira; Daniel T Pereira; Éverton N Alencar; Nicolas Tsapis; Eryvaldo Sócrates T Egito
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-13       Impact factor: 2.629

7.  A Type II Arabinogalactan from Anoectochilus formosanus for G-CSF Production in Macrophages and Leukopenia Improvement in CT26-Bearing Mice Treated with 5-Fluorouracil.

Authors:  Li-Chan Yang; Ting-Jang Lu; Wen-Chuan Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-26       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.